Recognizing and Promoting National HIT Week 2018

For Immediate Release: September 18, 2018 — Phoenix, AZ STATEMENT: PEPID, LLC announces it is an official National Health IT Week (NHIT Week) partner. NHIT Week 2018 is presented by the Healthcare Information and Management Systems Society (HIMSS) to promote the use...

PEPID Offers Hurricane Florence Relief

For Immediate Release: September 14, 2018 — Phoenix, AZ   STATEMENT: PEPID, LLC, the leading provider of point-of-care medical information and clinical decision support, gives free access of PEPID’s Suites to first responders and clinicians within the emergency...

FDA Approves First Generic EpiPen (epinephrine)

The FDA has approved the first generic version of Mylan’s EpiPEN and EpiPen Jr (epinephrine) auto injector used to treat emergency allergic reactions, such as the life-threatening anaphylaxis. The generic epinephrine auto-injector has been green flagged to market in...

First FDA Approved Targeted RNA-based Therapy

The U.S. FDA approved the first of its kind targeted RNA-based therapy Onpattro (patisiran) to treat peripheral nerve disease (polyneuropathy) caused from hereditary transthyretin-mediated amyloidosis (hATTR) in adult patients. This is the first FDA approved treatment...